{{Drugbox
| Watchedfields = changed
| verifiedrevid = 447440132
| IUPAC_name = (6''R'',7''R'')-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-<br>8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-<br>carboxylic acid
| image = Cefacetrile.svg

<!--Clinical data-->
| tradename = Celospor, Celtol, Cristacef
| Drugs.com = {{drugs.com|international|cefacetrile}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B  / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = [[靜脈注射|靜脈注射]]、[[肌肉注射|肌肉注射]]、乳房注射

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 23 to 38%
| metabolism = 
| elimination_half-life = 1.2小時
| excretion = [[腎臟|腎臟]] (72%)

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 10206-21-0
| ATC_prefix = J01
| ATC_suffix = DB10
| ATC_supplemental = {{ATCvet|J51|DB10}}
| PubChem = 91562
| ChEMBL = 2104099
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01414
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 82675
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = FDM21QQ344
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07629

<!--Chemical data-->
| C=13 | H=13 | N=3 | O=6 | S=1 
| molecular_weight = 339.325 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)CC#N)COC(=O)C)C(=O)O
| InChI = 1/C13H13N3O6S/c1-6(17)22-4-7-5-23-12-9(15-8(18)2-3-14)11(19)16(12)10(7)13(20)21/h9,12H,2,4-5H2,1H3,(H,15,18)(H,20,21)/t9-,12-/m1/s1
| InChIKey = RRYMAQUWDLIUPV-BXKDBHETBM
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H13N3O6S/c1-6(17)22-4-7-5-23-12-9(15-8(18)2-3-14)11(19)16(12)10(7)13(20)21/h9,12H,2,4-5H2,1H3,(H,15,18)(H,20,21)/t9-,12-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RRYMAQUWDLIUPV-BXKDBHETSA-N
}}
'''头孢乙腈'''（[[國際非專利藥品名稱|INN]]:Cefacetrile）是一種{{link-en|广谱抗菌素|Broad-spectrum antibiotic}}，是第一代的[[頭孢菌素|頭孢菌素]]，對[[革蘭氏陽性菌|革蘭氏陽性菌]]或[[革蘭氏陰性菌|革蘭氏陰性菌]]都有效，屬於{{link-en|制菌剂|Bacteriostatic}}<ref>{{cite web|url=http://www.emea.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011465.pdf|publisher=European Medicines Agency, Committee for Veterinary Medicinal Products|title=Cefacetrile Summary Report|year=1998|accessdate=2014-12-24|archive-date=2020-05-26|archive-url=https://web.archive.org/web/20200526024746/https://www.ema.europa.eu/en/documents/mrl-report/cefacetrile-summary-report-1-committee-veterinary-medicinal-products_en.pdf|dead-url=yes}}</ref><ref name="AC">{{cite book|title=Austria-Codex|editor=Haberfeld, H|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=2007/2008|isbn=3-85200-183-8|language=de}}</ref>。藥品的註冊名稱為'''Celospor'''、'''Celtol'''及'''Cristacef''',<ref>{{cite journal|title=[Clinical evaluation of cephacetrile (Celtol) for respiratory infections (author's transl)]|pages=1145–1155|issn=0368-2781|journal=The Japanese Journal of Antibiotics|volume=33|issue=10|date=1980-10|url=https://www.ncbi.nlm.nih.gov/pubmed/7206219|accessdate=2019-02-13|author=N. Horiuchi, Y. Oyakawa, R. Oka, T. Fujiwara|pmid=7206219|archive-date=2016-10-02|archive-url=https://web.archive.org/web/20161002004616/https://www.ncbi.nlm.nih.gov/pubmed/7206219/|dead-url=no}}</ref>，用在治療乳牛[[乳房|乳房]]感染的產品名稱是'''Vetimast'''<ref name="AC" />

==參考資料==
{{Reflist}}

{{CephalosporinAntiBiotics}}

[[Category:頭孢菌素|Category:頭孢菌素]]
[[Category:羧酸酯|Category:羧酸酯]]